pogosto kombinirano in vključuje kirurški
of treatment for this disease. Treatment is
poseg, obsevanje, kemoterapijo in ciljna
often combined and involves surgery, ra-
zdravila, ki blokirajo receptorje epidermal-
diation, chemotherapy and targeted drugs
nega rastnega faktorja, dejavnika, ki pospe-
that block the epidermal growth factor
šuje tumorsko razrast (Janez Eržen in Miha
receptor, a factor that promotes tumour
Sok, Ksenija Kocijančič in Igor Kocijančič,
growth (Janez Eržen and Miha Sok, Kseni-
Martina Vrankar in Uroš Smrdel, Vilijem
ja Kocijančič and Igor Kocijančič, Martina
Kovač, Matjaž Zwitter). Kot najpomembnej-
Vrankar and Uroš Smrdel, Viljem Kovač,
ši napovedni dejavniki so se pri pljučnem
Matjaž Zwitter). The most important pre-
raku pokazali klinični stadij bolezni, teles-
dictive factors in lung cancer were shown
na zmogljivost, komorbidnost, operativno
to be the clinical stage of the disease, phys-
zdravljenje in histologija tumorja ter sta-
ical capacity, co-morbidity, surgical treat-
rost bolnika (Lučka Debevec).
ment, tumour histology and the patient's age (Lučka Debevec).
1 Začetek simpozija s slovensko himno, v prvi vrsti z desne proti levi Tomaž Rott, Nina Gale, Matija Horvat, Vladislav Pegan, Bryan Corrin, London, Boštjan Žekš in dekan Dušan Šuput.
Start of the symposium with the Slovene anthem, (front row from right to left) Tomaž Rott, Nina Gale, Matija Horvat, Vladislav Pegan, Bryan Corrin, London, Boštjan Žekš and Dean Dušan Šuput.
2007
161